Abstract:Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year relative survival rate of 10.8%. After surgery, radiation and chemotherapy are the next lines of therapy. However, these treatments have not significantly improved clinical outcomes due in part to its unique and characteristic desmoplasia, which limits treatment efficacy. Cancer-associated fibroblasts (CAFs) have been shown to contribute in PDAC's stromal reaction in part viasecretion of extracellular matrix (ECM) components and growth factors, suggesting that CAFs are pro-tumorigenic. This understanding led to several CAF ablation preclinical studies; surprisingly, these studies demonstrated tumor-suppressive potential for CAFs, highlighting the functional heterogeneity among CAFs in PDAC. This emphasizes the need for greater developmental understanding of this influential cell population. Lineage tracing via our recently established Fabp4-Cre;Rosa26mTmG mouse model revealed that pancreatic stellate cells (PSCs), thought to be the main cellular origin of PDAC CAFs, contribute to a minor faction of CAFs yet appear to have non-redundant functions to alternatively-derived CAFs. Here we delve further into the specific functions of PSC-derived CAFs via single-cell RNA sequencing of pancreatic stellate cells in healthy and tumor pancreas with our Fabp4-Cre;Rosa26mTmG mouse model. To our surprise, initial scRNA-seq analysis illustrated that quiescent pancreatic stellate cells from healthy tissue appear to be more heterogeneous to PSC-derived CAFs, with quiescent pancreatic stellate cells clustering into three "super clusters" while PSC-derived CAFs clusters into one "super cluster". Additionally, clusters specific to normal pancreas tissue revealed potential transcripts-of-interest that are anti-tumorigenic. Current efforts seek to analyze stromal evolution with respect to CAF cell of origin in pre-malignant lesions and throughout stepwise tumorigenesis to metastasis. Furthermore, we are investigating the functional significance of potentially anti-tumorigenic factors lost from the PSC compartment upon differentiation to a CAF phenotype during PDAC progression. These findings shed light on the increasingly appreciated heterogeneity of PDAC CAFs, whilst suggesting that PSC-derived CAFs may be specifically targeted as a singular cell population for therapeutic treatment. Importantly, these findings help gain a greater understanding of PDAC disease progression and development in order to better serve patient care. Citation Format: M. Kathrina Casapao Onate, Matthew Schleisman, Zheng Xia, Mara H. Sherman. Distinct functions of pancreatic stellate cells in PDAC stromal evolution [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 3646.

Soluble Factors from Stellate Cells Induce Pancreatic Cancer Cell Proliferation Via Nrf2-Activated Metabolic Reprogramming and Ros Detoxification

The Critical Roles of Activated Stellate Cells-Mediated Paracrine Signaling, Metabolism and Onco-Immunology in Pancreatic Ductal Adenocarcinoma

Pancreatic Stellate Cells Increase the Invasion of Human Pancreatic Cancer Cells Through the Stromal Cell-Derived Factor-1/CXCR4 Axis

Effects and mechanisms of pancreatic stellate cells on proliferation of pacnreatic cancer cells

Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells

Paracrine Il-6 Signaling Mediates the Effects of Pancreatic Stellate Cells on Epithelial-Mesenchymal Transition Via Stat3/Nrf2 Pathway in Pancreatic Cancer Cells

PANCREATIC STELLATE CELLS STIMULATE PANCREATIC CANCER GROWTH AND METASTASIS

ESE3-positive PSCs Drive Pancreatic Cancer Fibrosis, Chemoresistance and Poor Prognosis Via Tumour-Stromal IL-1/NF-B/ESE3 Signalling Axis

Pancreatic Stellate Cells Facilitate Pancreatic Cancer Cell Viability and Invasion.

Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells

Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis

Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer

Activation Ofpancreatic Stellate Cells Involves an EMT-like Process

Pancreatic Stellate Cells Increase Pancreatic Cancer Cells Invasion Through the Hepatocyte Growth Factor /C-Met/survivin Regulated by P53/P21

Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21.

Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis

Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Cell Lines

Pancreatic Stellate Cells Promote Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells

Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth

Abstract 3646: Distinct functions of pancreatic stellate cells in PDAC stromal evolution